986 related articles for article (PubMed ID: 19474688)
1. Bisoprolol and fluvastatin for the reduction of perioperative cardiac mortality and myocardial infarction in intermediate-risk patients undergoing noncardiovascular surgery: a randomized controlled trial (DECREASE-IV).
Dunkelgrun M; Boersma E; Schouten O; Koopman-van Gemert AW; van Poorten F; Bax JJ; Thomson IR; Poldermans D;
Ann Surg; 2009 Jun; 249(6):921-6. PubMed ID: 19474688
[TBL] [Abstract][Full Text] [Related]
2. Fluvastatin and bisoprolol for the reduction of perioperative cardiac mortality and morbidity in high-risk patients undergoing non-cardiac surgery: rationale and design of the DECREASE-IV study.
Schouten O; Poldermans D; Visser L; Kertai MD; Klein J; van Urk H; Simoons ML; van de Ven LL; Vermeulen M; Bax JJ; Lameris TW; Boersma E
Am Heart J; 2004 Dec; 148(6):1047-52. PubMed ID: 15632892
[No Abstract] [Full Text] [Related]
3. Fluvastatin and perioperative events in patients undergoing vascular surgery.
Schouten O; Boersma E; Hoeks SE; Benner R; van Urk H; van Sambeek MR; Verhagen HJ; Khan NA; Dunkelgrun M; Bax JJ; Poldermans D;
N Engl J Med; 2009 Sep; 361(10):980-9. PubMed ID: 19726772
[TBL] [Abstract][Full Text] [Related]
4. Adrenergic receptor genotype but not perioperative bisoprolol therapy may determine cardiovascular outcome in at-risk patients undergoing surgery with spinal block: the Swiss Beta Blocker in Spinal Anesthesia (BBSA) study: a double-blinded, placebo-controlled, multicenter trial with 1-year follow-up.
Zaugg M; Bestmann L; Wacker J; Lucchinetti E; Boltres A; Schulz C; Hersberger M; Kälin G; Furrer L; Hofer C; Blumenthal S; Müller A; Zollinger A; Spahn DR; Borgeat A
Anesthesiology; 2007 Jul; 107(1):33-44. PubMed ID: 17585213
[TBL] [Abstract][Full Text] [Related]
5. Effect of bisoprolol on perioperative complications in chronic heart failure after surgery (Cardiac Insufficiency Bisoprolol Study II (CIBIS II)).
Böhm M; Maack C; Wehrlen-Grandjean M; Erdmann E
Z Kardiol; 2003 Aug; 92(8):668-76. PubMed ID: 12955414
[TBL] [Abstract][Full Text] [Related]
6. Effect of fluvastatin on cardiac outcomes in kidney transplant patients with systemic lupus erythematosus: a randomized placebo-controlled study.
Norby GE; Holme I; Fellström B; Jardine A; Cole E; Abedini S; Holdaas H;
Arthritis Rheum; 2009 Apr; 60(4):1060-4. PubMed ID: 19333947
[TBL] [Abstract][Full Text] [Related]
7. The effect of fluvastatin on cardiac outcomes in patients with moderate to severe renal insufficiency: a pooled analysis of double-blind, randomized trials.
Holdaas H; Wanner C; Abletshauser C; Gimpelewicz C; Isaacsohn J
Int J Cardiol; 2007 Apr; 117(1):64-74. PubMed ID: 16889855
[TBL] [Abstract][Full Text] [Related]
8. Preoperative statin therapy is associated with reduced cardiac mortality after coronary artery bypass graft surgery.
Collard CD; Body SC; Shernan SK; Wang S; Mangano DT; ;
J Thorac Cardiovasc Surg; 2006 Aug; 132(2):392-400. PubMed ID: 16872968
[TBL] [Abstract][Full Text] [Related]
9. Effect of statin withdrawal on frequency of cardiac events after vascular surgery.
Schouten O; Hoeks SE; Welten GM; Davignon J; Kastelein JJ; Vidakovic R; Feringa HH; Dunkelgrun M; van Domburg RT; Bax JJ; Poldermans D
Am J Cardiol; 2007 Jul; 100(2):316-20. PubMed ID: 17631090
[TBL] [Abstract][Full Text] [Related]
10. Fluvastatin reduces the impact of diabetes on long-term outcome after coronary intervention--a Lescol Intervention Prevention Study (LIPS) substudy.
Arampatzis CA; Goedhart D; Serruys PW; Saia F; Lemos PA; de Feyter P;
Am Heart J; 2005 Feb; 149(2):329-35. PubMed ID: 15846273
[TBL] [Abstract][Full Text] [Related]
11. Beneficial effect of early initiation of lipid-lowering therapy following renal transplantation.
Holdaas H; Fellström B; Jardine AG; Nyberg G; Grönhagen-Riska C; Madsen S; Neumayer HH; Cole E; Maes B; Ambühl P; Logan JO; Staffler B; Gimpelewicz C;
Nephrol Dial Transplant; 2005 May; 20(5):974-80. PubMed ID: 15784644
[TBL] [Abstract][Full Text] [Related]
12. [Organprotection in cardiac risk patients--rational of perioperative beta-adrenoceptor-antagonists and statins].
Hanss R; Bein B
Anasthesiol Intensivmed Notfallmed Schmerzther; 2010 Apr; 45(4):246-52; quiz 253. PubMed ID: 20387182
[TBL] [Abstract][Full Text] [Related]
13. Statins are associated with a reduced incidence of perioperative mortality after coronary artery bypass graft surgery.
Pan W; Pintar T; Anton J; Lee VV; Vaughn WK; Collard CD
Circulation; 2004 Sep; 110(11 Suppl 1):II45-9. PubMed ID: 15364837
[TBL] [Abstract][Full Text] [Related]
14. New developments in the preoperative evaluation and perioperative management of coronary artery disease in patients undergoing vascular surgery.
Bauer SM; Cayne NS; Veith FJ
J Vasc Surg; 2010 Jan; 51(1):242-51. PubMed ID: 19954922
[TBL] [Abstract][Full Text] [Related]
15. The effects of perioperative beta-blockade: results of the Metoprolol after Vascular Surgery (MaVS) study, a randomized controlled trial.
Yang H; Raymer K; Butler R; Parlow J; Roberts R
Am Heart J; 2006 Nov; 152(5):983-90. PubMed ID: 17070177
[TBL] [Abstract][Full Text] [Related]
16. The effect of bisoprolol on perioperative mortality and myocardial infarction in high-risk patients undergoing vascular surgery. Dutch Echocardiographic Cardiac Risk Evaluation Applying Stress Echocardiography Study Group.
Poldermans D; Boersma E; Bax JJ; Thomson IR; van de Ven LL; Blankensteijn JD; Baars HF; Yo TI; Trocino G; Vigna C; Roelandt JR; van Urk H
N Engl J Med; 1999 Dec; 341(24):1789-94. PubMed ID: 10588963
[TBL] [Abstract][Full Text] [Related]
17. Efficacy of folic acid when added to statin therapy in patients with hypercholesterolemia following acute myocardial infarction: a randomised pilot trial.
Liem AH; van Boven AJ; Veeger NJ; Withagen AJ; Robles de Medina RM; Tijssen JG; van Veldhuisen DJ;
Int J Cardiol; 2004 Feb; 93(2-3):175-9. PubMed ID: 14975544
[TBL] [Abstract][Full Text] [Related]
18. beta-Blockade in noncardiac surgery: outcome at all levels of cardiac risk.
Kaafarani HM; Atluri PV; Thornby J; Itani KM
Arch Surg; 2008 Oct; 143(10):940-4; discussion 944. PubMed ID: 18936371
[TBL] [Abstract][Full Text] [Related]
19. ß-Blockers reduce mortality in patients undergoing high-risk non-cardiac surgery.
Angeli F; Verdecchia P; Karthikeyan G; Mazzotta G; Gentile G; Reboldi G
Am J Cardiovasc Drugs; 2010; 10(4):247-59. PubMed ID: 20653331
[TBL] [Abstract][Full Text] [Related]
20. Rationale, design, and organization of the PeriOperative ISchemic Evaluation (POISE) trial: a randomized controlled trial of metoprolol versus placebo in patients undergoing noncardiac surgery.
; Devereaux PJ; Yang H; Guyatt GH; Leslie K; Villar JC; Monteri VM; Choi P; Giles JW; Yusuf S
Am Heart J; 2006 Aug; 152(2):223-30. PubMed ID: 16875901
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]